We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Further information on what drivers with different types of diabetes need to tell DVLA by law.
Data and statistics about walking and cycling, based on the National Travel Survey and Active Lives Survey.
The DOVE tool shows the relationship between spending on diabetes care and clinical outcomes in GP and clinical commissioning group (CCG) areas.
An interim review outlining progress towards achieving the 20% sugar reduction and the next steps.
Walking and cycling factsheets, based on the Active Lives Survey and National Travel Survey.
Explains the sugar recommendations in the Scientific Advisory Committee on Nutrition's (SACN's) carbohydrates and health report.
Research into the benefits of walking and cycling, including cost and health benefits, time saved and the effects on accident rates and congestion.
Report diabetes treated with Sulphonylureas or Glinide tablets to DVLA if you're a lorry, bus or coach driver.
Data about participating in walking and cycling, road safety, journey times and social attitudes, produced by Department for Transport.
Analysis of risk factors for pre-diabetes (also called non-diabetic hyperglycaemia, or NDH) and undiagnosed type 2 diabetes among adults.
This treaty was presented to Parliament in March 2023.
Data about walking and cycling, based on the Active Lives Survey.
How to optimise the NHS Diabetes Prevention Programme in order to identify those at risk of Type 2 diabetes and help lower their risk of developing the disease.
This treaty was presented to Parliament in July 2019.
The VIA tool shows how inpatient activity for patients with diabetes differs from a similar patient population without diabetes.
Regulatory Policy Committee opinion on DHSC's impact assessment of the restricting volume promotions for high fat sugar and salt products.
Effects of cash transfers on health-seeking behaviour, service use, and clinical outcomes among Syrian refugees with type II diabetes in Jordan
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).